Oil-Dri Named One of the Top 100 Finalists for the 23rd Annual Chicago Innovation Awards
September 27, 2024 10:30 ET
|
Oil-Dri Corporation Of America
CHICAGO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Out of 350 nominees, Oil-Dri Corporation of America (NYSE: ODC), headquartered in Chicago, has been selected as one of the Top 100 Finalists in the...
Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
September 27, 2024 10:22 ET
|
Knight Therapeutics
MONTREAL, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 397 on the 2024 Report on Business magazine’s...
Bank of America Named Best in Class in Javelin’s 2024 Cyber Trust in Banking Scorecard
September 27, 2024 10:10 ET
|
Javelin Strategy & Research
SAN FRANCISCO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Javelin Strategy & Research released its 2024 2024 Cyber Trust in Banking Scorecard today, revealing that privacy is the key driver of...
Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
September 27, 2024 09:35 ET
|
Regeneron Pharmaceuticals, Inc.
Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype Following...
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
September 27, 2024 09:35 ET
|
Sanofi - Aventis Groupe
Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled...
Qifu Technology Responds to Short Seller Report
September 27, 2024 09:27 ET
|
Qifu Technology, Inc.
SHANGHAI, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today issues the...
Diabetes Drugs Global Strategic Business Report 2024: Market to Surpass $205 Billion by 2030 - Development of GLP-1 Receptor Agonists Expands Treatment Options
September 27, 2024 09:19 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Diabetes Drugs...
Surfing Boards Global Strategic Business Report 2024-2030 Featuring Quiksilver, Gul Watersports, Fox Head, Boardriders, Body Glove, Decathlon, and Agit Global
September 27, 2024 09:09 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Surfing Boards - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Surfing Boards is...
Hammond Power Solutions Closes $65.5 Million Bought Deal Secondary Offering
September 27, 2024 09:00 ET
|
Hammond Power Solutions Inc
GUELPH, Ontario, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) announced today that Chair of Board, Mr. William G. Hammond, through a company...
Foresight Signs Multi-Phase Collaboration Agreement with BuilderX
September 27, 2024 08:50 ET
|
Foresight Autonomous Holdings Ltd.
Following successful POC project completion, the parties will develop and commercialize AI tele-operations solutions for heavy machinery to improve safety in hazardous industrial environments. Ness...